Endothelin- and neuropeptide Y-induced vasoconstriction of human epicardial coronary arteries in vitro.
about
Nitric oxide-mediated modulation of the endothelin-1 signalling pathway in the human cardiovascular systemPhysiological antagonism of endothelin-1 in human conductance and resistance coronary arteryETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitroCharacterization of [125I]-PD164333, an ETA selective non-peptide radiolabelled antagonist, in normal and diseased human tissuesEndothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-typeEndothelin receptor subtypes and their functional relevance in human small coronary arteriesComparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1.Endogenous plasma endothelin concentrations and coronary circulation in patients with mild dilated cardiomyopathy.Effects of calcium antagonists on endothelin-1-induced myocardial ischaemia and oedema in the ratEndothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2Evidence for heterogeneity of endothelin receptor distribution in human coronary artery.Characterization of the snake venom ligand [125I]-DNP binding to natriuretic peptide receptor-A in human artery and potent DNP mediated vasodilatation.Regional heterogeneity in the contractile and potentiating effects of neuropeptide Y in rat isolated coronary arteries: modulatory action of the endotheliumEndothelin infusion reduces hypoxic pulmonary hypertension in pigs in vivo.The therapeutic potential of PD156707 and related butenolide endothelin antagonists.Neuropeptide Y in human hand veins: Pharmacologic characterization and interaction with cyclic guanosine monophosphate-dependent venodilators in vivo*
P2860
Q28345869-B4B94B22-54C2-4EDB-BC58-64637DE26173Q28366585-D4BE58E3-3A3E-4AC6-A1B8-D397FF1CFB10Q28367973-71FA3129-2EA0-42C6-86C0-D4AAC1DED67FQ28379363-72D6306C-D9FB-454B-90D3-8115F8E9FB04Q34793212-B50C44B4-0C34-4075-AAF4-522D29DEAF89Q35027611-E9A7F7AC-7C67-4B11-B252-C71B31176C46Q35044504-F2D5B180-2200-4A55-96C2-4DD2B97E0634Q35371066-6EDA0CBB-184E-4541-B4AC-751B462C6E1CQ35873579-03B31F58-6329-44A9-840D-AE9F19EFECCEQ35874597-C6EA2B4C-5BB3-4E7E-80B3-693FBA55FFEEQ36329836-5E416095-639F-4042-B65E-2135C63CEFB1Q41604430-3E677E3D-9804-4BAA-8358-0075E1FBAF8BQ42561358-F75CE13A-01E4-41BA-861A-BD2F2E10647DQ51598687-E04E0234-A38F-4730-BA58-4F2BB657C6E7Q53852762-0278F402-CD40-47D2-89D9-B44C5D7A4BBBQ56832856-CD7E82DB-BB21-4E05-81FC-1CEB6ED68669
P2860
Endothelin- and neuropeptide Y-induced vasoconstriction of human epicardial coronary arteries in vitro.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Endothelin- and neuropeptide Y ...... al coronary arteries in vitro.
@ast
Endothelin- and neuropeptide Y ...... al coronary arteries in vitro.
@en
type
label
Endothelin- and neuropeptide Y ...... al coronary arteries in vitro.
@ast
Endothelin- and neuropeptide Y ...... al coronary arteries in vitro.
@en
prefLabel
Endothelin- and neuropeptide Y ...... al coronary arteries in vitro.
@ast
Endothelin- and neuropeptide Y ...... al coronary arteries in vitro.
@en
P2860
P1476
Endothelin- and neuropeptide Y ...... al coronary arteries in vitro.
@en
P2093
Franco-Cereceda A
P2860
P304
P356
10.1111/J.1476-5381.1989.TB12038.X
P407
P577
1989-07-01T00:00:00Z